
Ivaryt 5mg Tablet
Marketer
Bluewaterresearch
Salt Composition
Ivabradine (5mg)
Overview Ivaryt 5mg Tablet
Cardilux 5mg tablets treat angina (chest pain stemming from heart problems) and chronic heart failure. It improves cardiac efficiency by reducing heart rate, easing chest pain and lowering the risk of hospitalization for heart failure patients. Dosage depends on the specific condition. Because treatment is typically lifelong, discontinuation requires physician consultation. Take it daily with food at the same time. Overdosing can cause excessive heart rate slowing, breathlessness, and fatigue; seek immediate medical help if this occurs. Common side effects include fleeting visual brightness, bradycardia, hypertension, atrial fibrillation, dizziness, blurred vision, and electrocardiographic alterations. Serious side effects like syncope and significant heart rhythm changes necessitate urgent medical attention. Refrain from driving until the medication's effects are known. Do not use Cardilux 5mg tablets if you have severe hepatic impairment, bradycardia, or arrhythmia. It's unsuitable for those with severe hypotension and recently exacerbated heart failure. This medication interacts with certain antihypertensives, antifungals, and antiretrovirals. Avoid use during pregnancy, attempts at conception, or breastfeeding.
Primary Ingredients of Ivaryt 5mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Ivaryt 5mg Tablet
Management of angina pectoris (chest pain of cardiac origin) | Cardiac failure management
Major Benefits of Ivaryt 5mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the 5mg Ivaryt tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.
Common Side effects of Ivaryt 5mg Tablet:
- Slow heart rate
- Luminous phenomena (Enhanced brightness)
- High blood pressure
- Atrial fibrillation
- Dizziness
- Blurred vision
- ECG changes
How to use Ivaryt 5mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the 5mg Ivaryt tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.
How Ivaryt 5mg Tablet works:
Cardiolyn 5mg tablets decrease cardiac rhythm, thereby diminishing the heart's oxygen demand and improving its overall performance.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of Ivaryt 5mg Tablet and alcohol is undetermined. Seek medical advice before combining them.
PregnancyUNSAFE
The use of Ivaryt 5mg tablets is strongly contraindicated during pregnancy. Pregnant women should consult their physician; research in both animals and pregnant humans indicates substantial risks to fetal development.
Breast feedingUNSAFE
Using Ivaryt 5mg tablets while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be impaired by Ivaryt 5mg Tablet, a medication that can induce transient visual disturbances, primarily phosphenes. Night driving, in particular, warrants consideration of this potential side effect.
KidneyCAUTION
Patients with severe kidney impairment should use Ivaryt 5mg tablets cautiously. A dose modification of Ivaryt 5mg tablets may be necessary. Physician consultation is advised. Data regarding Ivaryt 5mg tablet use in patients with severe renal disease is limited.
LiverCAUTION
Patients with hepatic impairment should use Ivaryt 5mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Ivaryt 5mg tablets are contraindicated in patients with severe liver dysfunction.
What if you forget to take Ivaryt 5mg Tablet :
Omit any missed Ivaryt 5mg Tablet dose and resume your regular medication schedule. Avoid taking a double dose.
Facts to Know About Ivaryt 5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Benzazepine-based compound |
| Developing Habits | No. |
| Treatment Category | Heart |
| Actions | Sodium channel blockers targeting the sinoatrial node I<sub>f</sub> current |
